相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation
Patricia Perez-Galan et al.
BLOOD (2011)
Activation of the Endoplasmic Reticulum Stress-Associated Transcription Factor X Box-Binding Protein-1 Occurs in a Subset of Normal Germinal-Center B Cells and in Aggressive B-Cell Lymphomas with Prognostic Implications
Olga Balague et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study
A. Goy et al.
ANNALS OF ONCOLOGY (2009)
Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling
Silvia Bea et al.
BLOOD (2009)
2-D PAGE-based comparison of proteasome inhibitor bortezomib in sensitive and resistant mantle cell lymphoma
Marc Weinkauf et al.
ELECTROPHORESIS (2009)
Characterization of the ubiquitin-proteasome system in bortezomib-adapted cells
T. Rueckrich et al.
LEUKEMIA (2009)
Dysregulation of unfolded protein response partially underlies proapoptotic activity of bortezomib in multiple myeloma cells
Hongjuan Dong et al.
LEUKEMIA & LYMPHOMA (2009)
ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells
Qiuyan Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mantle Cell Lymphoma: Biological Insights and Treatment Advances
John P. Leonard et al.
CLINICAL LYMPHOMA & MYELOMA (2009)
The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies
Luca Paoluzzi et al.
BLOOD (2008)
Molecular basis of bortezomib resistance:: proteasome subunit β5 (PSMB5) gene mutation and overexpression of PSMB5 protein
Ruud Oerlemans et al.
BLOOD (2008)
Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis
Marissa V. Powers et al.
CANCER CELL (2008)
Untangling the unfolded protein response
Emma L. Davenport et al.
CELL CYCLE (2008)
Targeting Hsp90: small-molecule inhibitors and their clinical development
Tony Taldone et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Mechanisms of proteasome inhibitor action and resistance in cancer
David J. McConkey et al.
DRUG RESISTANCE UPDATES (2008)
Therapy of Mantle Cell Lymphoma: Current Standards and Future Strategies
Christian Schmidt et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2008)
Point mutation of the proteasome β5 subunit gene is an important mechanism of bortezomib resistance in bortezomib-selected variants of Jurkat T cell lymphoblastic lymphoma/leukemia line
Shuqing Lu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma
David T. Yang et al.
MOLECULAR CANCER (2008)
Novel approaches for the treatment of NHL: Proteasome inhibition and immune modulation
Owen A. O'Connor et al.
LEUKEMIA & LYMPHOMA (2008)
Cyclin D1 mediates resistance to apoptosis through upregulation of molecular chaperones and consequent redistribution of cell death regulators
G. Roue et al.
ONCOGENE (2008)
IPI-504, a novel and soluble HSP-90 inhibitor, blocks the unfolded protein response in multiple myeloma cells
Jon Patterson et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics
Pedro Jares et al.
NATURE REVIEWS CANCER (2007)
Heat shock protein inhibition is associated with activation of the unfolded protein response pathway in myeloma plasma cells
Emma L. Davenport et al.
BLOOD (2007)
ER chaperones in mammalian development and human diseases
Min Ni et al.
FEBS LETTERS (2007)
The BH3-mimetic GX15-070 synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of Bak
Patricia Perez-Galan et al.
BLOOD (2007)
Selective inhibition of IκB kinase sensitizes mantle cell lymphoma B cells to TRAIL by decreasing cellular FLIP level
Gael Roue et al.
JOURNAL OF IMMUNOLOGY (2007)
Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90
Jens R. Sydor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma
Richard I. Fisher et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90
Jie Ge et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib
Reshma Shringarpure et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells
Esther A. Obeng et al.
BLOOD (2006)
Localization of GRP78 to mitochondria under the unfolded protein response
Fang-Chun Sun et al.
BIOCHEMICAL JOURNAL (2006)
Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells
AC Ranganathan et al.
CANCER RESEARCH (2006)
Antimyeloma activity of heat shock protein-90 inhibition
CS Mitsiades et al.
BLOOD (2006)
The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status
P Perez-Galan et al.
BLOOD (2006)
Mediators of endoplasmic reticulum stress-induced apoptosis
Eva Szegezdi et al.
EMBO REPORTS (2006)
Intracellular protein degradation and its therapeutic implications
T Hideshima et al.
CLINICAL CANCER RESEARCH (2005)
Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-β precursor protein-overexpressing cultured human muscle fibers
P Fratta et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma
OA O'Connor et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Herp is dually regulated by both the endoplasmic reticulum stress-specific branch of the unfolded protein response and a branch that is shared with other cellular stress pathways
YJ Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress
Y Kawaguchi et al.
CELL (2003)
Translational control in the endoplasmic reticulum stress response
D Ron
JOURNAL OF CLINICAL INVESTIGATION (2002)
Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation
KJ Travers et al.
CELL (2000)
分享论文
